Get started
Author

Olga Odanović

Observed names: O Odanovic, Odanović, Olga, Olga Odanovic
OpenAlex ID: A5085600066
The effects of synbiotics on the liver steatosis, inflammation, and gut microbiome of metabolic dysfunction-associated liver disease patients-randomized trial
2024 · Miloš Mitrović, Ana Dobrosavljević, et al. · Romanian Journal of Internal Medicine · 30
PDF
Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World Pharmacokinetics
2024 · Srđan Marković, Đorđe Kralj, et al. · Pharmaceutics · 6
PDF
Review and External Evaluation of Population Pharmacokinetic Models for Vedolizumab in Patients with Inflammatory Bowel Disease: Assessing Predictive Performance and Clinical Applicability
2024 · Marija Jovanović, Ana Homšek, et al. · Biomedicines · 3
PDF
Arterial Thrombosis in Severe Ulcerative Colitis: A Case-Based Narrative Review of Current Evidence
2026 · Djordje Kralj, Mladen Maksic, et al. · Biomedicines · 1
PDF
P0996 Advanced Therapies Reshape Liver Steatosis Outcomes in Inflammatory Bowel Disease: A Prospective Cohort Analysis
2026 · M Mitrovic, T Knezevic, et al. · Journal of Crohn s and Colitis · 1
P330 Immunity in patients with inflammatory bowel disease on biologic therapy after COVID, 19 vaccination
2022 · T Knezevic, D Cujic, et al. · Journal of Crohn s and Colitis · 1
P1187 Human Papillomavirus Epidemiology in Anti-TNFα–Treated Women: Contrasting Patterns Between Inflammatory Bowel Disease Patients and Rheumatoid Arthritis
2026 · M Mitrovic, T Knezevic, et al. · Journal of Crohn s and Colitis
P0209 Building Serbia’s First IBD Data Warehouse: Early Results from Serbia’s BIOTHER IBD Platform
2026 · T Knezevic, R Matic, et al. · Journal of Crohn s and Colitis
PDF
Ep72: Albumin as a Predictor of Response to Rescue Therapy in Acute Severe Ulcerative Colitis: a Retrospective Study
2025 · Tamara Knezevic Ivanovski, Olga Odanovic, et al. · Gastroenterology
P1124 Disease Clearence after Acute Severe Ulcerative Colitis episode: is it possible ?
2025 · S Markovic, Đ Kralj, et al. · Journal of Crohn s and Colitis
P0623 Vedolizumab clearance as a predictor of remission in inflammatory bowel disease: a real-world pharmacokinetic study
2025 · S Markovic, D Kralj, et al. · Journal of Crohn s and Colitis
P838 Determing factors that influence Vedolizumab Response in Inflammatory Bowel Diseases: A Prospective Study
2024 · T Knezevic, A Dobrosavljevic, et al. · Journal of Crohn s and Colitis
PDF
Anemia in inflammatory bowel diseases treated by liposomal iron
2023 · Srđan Marković, Đorđe Kralj, et al. · AFMN Biomedicine
PDF
P792 Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patients
2023 · S Markovic, D Kralj, et al. · Journal of Crohn s and Colitis
PDF
Population pharmacokinetic model of infliximab in patients with fistulising Crohn’s disease
2023 · Homšek, Ana, Marković, Srđan, et al. · FarFar - Pharmacy Repository
Works count: 15
Citation count: 42
H-index: 3
I10-index: 1
Year
Topic
Type